Greytown Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $817K | Sell |
8,812
-384
| -4% | -$35.6K | 0.48% | 30 |
|
|
2024
Q1 | $873K | Sell |
9,196
-2,886
| -24% | -$274K | 0.49% | 27 |
|
|
2023
Q4 | $1.08M | Sell |
12,082
-1,434
| -11% | -$128K | 0.58% | 28 |
|
|
2023
Q3 | $987K | Buy |
13,516
+82
| +0.6% | +$5.99K | 0.55% | 28 |
|
|
2023
Q2 | $1.12M | Sell |
13,434
-98
| -0.7% | -$8.15K | 0.61% | 27 |
|
|
2023
Q1 | $1.03M | Hold |
13,532
| – | – | 0.53% | 28 |
|
|
2022
Q4 | $1.12M | Buy |
13,532
+962
| +8% | +$79.8K | 0.61% | 25 |
|
|
2022
Q3 | $997K | Buy |
12,570
+1,205
| +11% | +$95.6K | 0.6% | 26 |
|
|
2022
Q2 | $844K | Buy |
11,365
+3,224
| +40% | +$239K | 0.48% | 37 |
|
|
2022
Q1 | $732K | Buy |
+8,141
| New | +$732K | 0.35% | 53 |
|